CD34 and acute myeloid leukemia: Wu et al. identified TIM-3 as an independent predictor of poor disease-free survival (DFS) in a comprehensive analysis of the AML cohort from TCGA, and its expression in CD45+CD34+ stem/progenitor cells independently predicted event-free survival (EFS) and OS by MFC [6].